| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-12 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.24 | 9e-07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |